{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:53:51Z","timestamp":1788353631155,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["396291"],"award-info":[{"award-number":["396291"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["396291"],"award-info":[{"award-number":["396291"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12029-019-00332-8","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T06:13:29Z","timestamp":1593756809000},"page":"676-681","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Evaluation of the Effects of Valproic Acid Treatment on Cell Survival and Epithelial-Mesenchymal Transition-Related Features of Human Gastric Cancer Cells"],"prefix":"10.1007","volume":"52","author":[{"given":"Mehrnaz","family":"Jahani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Khanahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1784-6040","authenticated-orcid":false,"given":"Parvaneh","family":"Nikpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,3]]},"reference":[{"issue":"18","key":"332_CR1","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.3748\/wjg.v20.i18.5403","volume":"20","author":"Z Peng","year":"2014","unstructured":"Peng Z, Wang C-X, Fang E-H, Wang G-B, Tong Q. Role of epithelial-mesenchymal transition in gastric cancer initiation and progression. World J Gastroenterol. 2014;20(18):5403\u201310.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"332_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1600-0463.2005.apm_04.x","volume":"113","author":"J Song","year":"2005","unstructured":"Song J, Noh JH, Lee JH, Eun JW, Ahn YM, Kim SY, et al. Increased expression of histone deacetylase 2 is found in human gastric cancer. Apmis. 2005;113(4):264\u20138.","journal-title":"Apmis"},{"issue":"3","key":"332_CR3","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.3892\/mmr.2015.3816","volume":"12","author":"DG Fu","year":"2015","unstructured":"Fu DG. Epigenetic alterations in gastric cancer. Mol Med Rep. 2015;12(3):3223\u201330.","journal-title":"Mol Med Rep"},{"issue":"5","key":"332_CR4","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.3892\/ol.2016.4337","volume":"11","author":"J Ma","year":"2016","unstructured":"Ma J, Shen H, Kapesa L, Zeng S. Lauren classification and individualized chemotherapy in gastric cancer. Oncol Lett. 2016;11(5):2959\u201364.","journal-title":"Oncol Lett"},{"issue":"25","key":"332_CR5","doi-asserted-by":"publisher","first-page":"6220","DOI":"10.1200\/JCO.2005.11.593","volume":"23","author":"L Lim","year":"2005","unstructured":"Lim L, Michael M, Mann GB, Leong T. Adjuvant therapy in gastric cancer. J Clin Oncol. 2005;23(25):6220\u201332. https:\/\/doi.org\/10.1200\/JCO.2005.11.593.","journal-title":"J Clin Oncol"},{"issue":"1","key":"332_CR6","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1684\/bdc.2013.1882","volume":"101","author":"X Jin","year":"2014","unstructured":"Jin X, Zhu Z, Shi Y. Metastasis mechanism and gene\/protein expression in gastric cancer with distant organs metastasis. Bull Cancer. 2014;101(1):E1\u201312.","journal-title":"Bull Cancer"},{"issue":"3","key":"332_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"332_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrd.2015.13","volume":"15","author":"F Marcucci","year":"2016","unstructured":"Marcucci F, Stassi G, De Maria R. Epithelial\u2013mesenchymal transition: a new target in anticancer drug discovery. Nat Rev Drug Discov. 2016;15(5):311\u201325.","journal-title":"Nat Rev Drug Discov"},{"key":"332_CR9","unstructured":"Pourian A. The effect of valproic acid on histone acetylation in FaDu-luc head and neck squamous cell carcinoma cells: University of Iowa; 2011."},{"issue":"5","key":"332_CR10","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.3892\/or.2015.3879","volume":"33","author":"M Ji","year":"2015","unstructured":"Ji M, Lee EJ, Kim KB, Kim Y, Sung R, Lee S-J, et al. HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells. Oncol Rep. 2015;33(5):2299\u2013308.","journal-title":"Oncol Rep"},{"issue":"1","key":"332_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","volume":"1","author":"S Ropero","year":"2007","unstructured":"Ropero S, Esteller M. The role of histone deacetylases (HDACs) in human cancer. Mol Oncol. 2007;1(1):19\u201325.","journal-title":"Mol Oncol"},{"issue":"37","key":"332_CR12","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.1038\/sj.onc.1210610","volume":"26","author":"M Glozak","year":"2007","unstructured":"Glozak M, Seto E. Histone deacetylases and cancer. Oncogene. 2007;26(37):5420\u201332.","journal-title":"Oncogene"},{"issue":"10","key":"332_CR13","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1586\/14737140.2014.940329","volume":"14","author":"SA Brodie","year":"2014","unstructured":"Brodie SA, Brandes JC. Could valproic acid be an effective anticancer agent? The evidence so far. Expert Rev Anticancer Ther. 2014;14(10):1097\u2013100.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"24","key":"332_CR14","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M G\u00f6ttlicher","year":"2001","unstructured":"G\u00f6ttlicher M, Minucci S, Zhu P, Kr\u00e4mer OH, Schimpf A, Giavara S, et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 2001;20(24):6969\u201378.","journal-title":"EMBO J"},{"issue":"2","key":"332_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s13277-010-0126-5","volume":"32","author":"X Zhao","year":"2011","unstructured":"Zhao X, Yang W, Shi C, Ma W, Liu J, Wang Y, et al. The G1 phase arrest and apoptosis by intrinsic pathway induced by valproic acid inhibit proliferation of BGC-823 gastric carcinoma cells. Tumor Biol. 2011;32(2):335\u201346.","journal-title":"Tumor Biol"},{"key":"332_CR16","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2147\/OTT.S83114","volume":"8","author":"S Fushida","year":"2015","unstructured":"Fushida S, Kaji M, Oyama K, Hirono Y, Nezuka H, Takeda T, et al. Randomized phase II trial of paclitaxel plus valproic acid vs paclitaxel alone as second-line therapy for patients with advanced gastric cancer. OncoTargets Ther. 2015;8:939.","journal-title":"OncoTargets Ther"},{"issue":"6","key":"332_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/19336918.2015.1112486","volume":"9","author":"J Feng","year":"2015","unstructured":"Feng J, Cen J, Li J, Zhao R, Zhu C, Wang Z, et al. Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail. Cell Adhes Migr. 2015;9(6):495\u2013501.","journal-title":"Cell Adhes Migr"},{"issue":"5","key":"332_CR18","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.3892\/ijo.2016.3712","volume":"49","author":"A Kanamoto","year":"2016","unstructured":"Kanamoto A, Ninomiya I, Harada S, Tsukada T, Okamoto K, Nakanuma S, et al. Valproic acid inhibits irradiation-induced epithelial-mesenchymal transition and stem cell-like characteristics in esophageal squamous cell carcinoma. Int J Oncol. 2016;49(5):1859\u201369.","journal-title":"Int J Oncol"},{"issue":"5","key":"332_CR19","doi-asserted-by":"publisher","first-page":"6190","DOI":"10.3892\/mmr.2017.7394","volume":"16","author":"S Mao","year":"2017","unstructured":"Mao S, Lu G, Lan X, Yuan C, Jiang W, Chen Y, et al. Valproic acid inhibits epithelialmesenchymal transition in renal cell carcinoma by decreasing SMAD4 expression. Mol Med Rep. 2017;16(5):6190\u20139. https:\/\/doi.org\/10.3892\/mmr.2017.7394.","journal-title":"Mol Med Rep"},{"key":"332_CR20","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.biopha.2016.10.023","volume":"84","author":"L Wu","year":"2016","unstructured":"Wu L, Feng H, Hu J, Tian X, Zhang C. Valproic acid (VPA) promotes the epithelial mesenchymal transition of hepatocarcinoma cells via transcriptional and post-transcriptional up regulation of Snail. Biomed Pharmacother. 2016;84:1029\u201335.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"332_CR21","first-page":"614","volume":"66","author":"L Zhang","year":"2011","unstructured":"Zhang L, Wang G, Wang L, Song C, Wang X, Kang J. Valproic acid inhibits prostate cancer cell migration by up-regulating E-cadherin expression. Pharmazie. 2011;66(8):614\u20138.","journal-title":"Pharmazie"},{"issue":"1","key":"332_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00432-015-2020-4","volume":"142","author":"X Lan","year":"2016","unstructured":"Lan X, Lu G, Yuan C, Mao S, Jiang W, Chen Y, et al. Valproic acid (VPA) inhibits the epithelial\u2013mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4. J Cancer Res Clin Oncol. 2016;142(1):177\u201385.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"10","key":"332_CR23","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.22038\/IJBMS.2017.9448","volume":"20","author":"M Nasrollahzadeh-Khakiani","year":"2017","unstructured":"Nasrollahzadeh-Khakiani M, Emadi-Baygi M, Nikpour P. Augmented expression levels of lncRNAs ecCEBPA and UCA1 in gastric cancer tissues and their clinical significance. Iran J Basic Med Sci. 2017;20(10):1149\u201358. https:\/\/doi.org\/10.22038\/IJBMS.2017.9448.","journal-title":"Iran J Basic Med Sci"},{"key":"332_CR24","doi-asserted-by":"crossref","unstructured":"Xie C, Edwards H, Xu X, Zhou H, Buck S, Stout M, et al. Mechanisms of synergistic antileukemic interactions between valproic acid and cytarabine in pediatric acute myeloid leukemia. Clin Cancer Res. 2010.","DOI":"10.1158\/1078-0432.CCR-10-1707"},{"issue":"3","key":"332_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/jb\/mvn074","volume":"144","author":"S Sami","year":"2008","unstructured":"Sami S, H\u00f6ti N, Xu H-M, Shen Z, Huang X. Valproic acid inhibits the growth of cervical cancer both in vitro and in vivo. J Biochem. 2008;144(3):357\u201362.","journal-title":"J Biochem"},{"issue":"10","key":"332_CR26","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1097\/01.cad.0000236302.89843.fc","volume":"17","author":"A Angelucci","year":"2006","unstructured":"Angelucci A, Valentini A, Millimaggi D, Gravina GL, Miano R, Dolo V, et al. Valproic acid induces apoptosis in prostate carcinoma cell lines by activation of multiple death pathways. Anti-Cancer Drugs. 2006;17(10):1141\u201350.","journal-title":"Anti-Cancer Drugs"},{"issue":"14","key":"332_CR27","doi-asserted-by":"publisher","first-page":"10678","DOI":"10.1074\/jbc.M109.057836","volume":"285","author":"V Venkataramani","year":"2010","unstructured":"Venkataramani V, Rossner C, Iffland L, Schweyer S, Tamboli IY, Walter J, et al. Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein. J Biol Chem. 2010;285(14):10678\u201389.","journal-title":"J Biol Chem"},{"key":"332_CR28","unstructured":"Aghagolzade Haji H, Khoshbin Khoshnazar A, Gharaei R, Javan B, Asadi J. Effect of valproic acid and radiotherapy on viability of MCF-7 breast cancer cell line. J Gorgan Univ Med Sci. 2014;16(3)."},{"key":"332_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1471-2407-12-91","volume":"12","author":"AM Haslehurst","year":"2012","unstructured":"Haslehurst AM, Koti M, Dharsee M, Nuin P, Evans K, Geraci J, et al. EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. BMC Cancer. 2012;12:91. https:\/\/doi.org\/10.1186\/1471-2407-12-91.","journal-title":"BMC Cancer"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-019-00332-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-019-00332-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-019-00332-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T13:23:30Z","timestamp":1628601810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-019-00332-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["332"],"URL":"https:\/\/doi.org\/10.1007\/s12029-019-00332-8","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,3]]},"assertion":[{"value":"3 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}